Oncology News
- ASCO 2023 CAR-T Hikes Overall Survival in Relapsed/Refractory LBCL
- ASCO 2023 'Remarkable': CAR T Therapy for CLL/SLL
- VA Study Finds Lower Racial Disparity in Melanoma Diagnoses
- Antibiotic Prophylaxis May Lower SSIs in Skin Cancer Surgery
- WHO Advises Against Nonsugar Sweeteners for Weight Control
- ASCO 2023 Multiprong Strategy Makes Clinical Trials Less White
- ASCO 2023 DEI Training Gives Oncology Fellows More Confidence
- Is ChatGPT a Friend or Foe of Medical Publishing?
- ASCO 2023 First or Second-Line CDK4/6 Inhibition in Breast Cancer?
- Sequencing Strategy in Ovarian Cancer Helps Guide Treatment
- Metronomic Therapy Effective in Head and Neck Cancer
- ASCO 2023 PMBCL: Postremission, Patients May Safely Skip Radiation
- Widespread Carboplatin, Cisplatin Shortages: NCCN Survey
- Palliative Care Laws Make a Difference for Cancer Patients
- Cognitive Decline Risk in Adult Childhood Cancer Survivors
- Risk of Falls With Newer Antiandrogens for Prostate Cancer
- ASCO 2023 Huge Underuse of Germline Testing for Cancer Patients
- ASCO 2023 CAR T-Cell Benefit in Lenalidomide-Refractory Myeloma
- ASCO 2023 T-DXd Active in Many Solid Tumors; 'Shift in Thinking'
- ASCO 2023 Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer